Table of Content

1 INTRODUCTION (Page No. - 20)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 RESEARCH LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH DATA 
          FIGURE 1 ULTRASOUND MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 MARKET SIZE ESTIMATION FOR ULTRASOUND INDUSTRY: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                                FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF GE HEALTHCARE
                    2.2.1.2 Approach 2: Customer-based market estimation
                    2.2.1.3 market: Top-down approach
                    2.2.1.4 CAGR projection
                                FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
    2.3 DATA VALIDATION APPROACH 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ASSESSMENT 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
           2.6.1 MARKET: RISK ASSESSMENT
    2.7 GROWTH RATE ASSUMPTIONS 
    2.8 MARKET: RECESSION IMPACT 
3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 ULTRASOUND INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 MARKET, BY PORTABILITY, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 ULTRASOUND MARKET OVERVIEW 
          FIGURE 14 INCREASING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT RISE IN SURGICAL PROCEDURES TO DRIVE MARKET
    4.2 EUROPE: ULTRASOUND INDUSTRY, BY TECHNOLOGY (USD MILLION) 
          FIGURE 15 DIAGNOSTIC ULTRASOUND SEGMENT TO HOLD LARGEST SHARE
    4.3 ASIA PACIFIC: MARKET, BY END USER 
          FIGURE 16 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 MARKET, BY DISPLAY TYPE 
          FIGURE 17 COLOR ULTRASOUND SEGMENT TO COMMAND LARGEST SHARE TILL 2028
    4.5 GEOGRAPHIC SNAPSHOT OF MARKET 
          FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 46)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing incidence of target diseases and subsequent rise in surgical procedures
                    5.2.1.2 Growing patient preference for minimally invasive surgeries
                    5.2.1.3 Rising technological advancements in ultrasound devices
                    5.2.1.4 Growing public-private investments for product commercialization
                    5.2.1.5 Increasing establishment of hospitals and diagnostic centers
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable reimbursements
                    5.2.2.2 High operating costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing applications of therapeutic ultrasound
                    5.2.3.2 High growth potential of emerging markets
                    5.2.3.3 Development of POC ultrasound systems
           5.2.4 CHALLENGES
                    5.2.4.1 Growing end-user preference for refurbished equipment
                    5.2.4.2 Shortage of skilled sonographers
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 1 ULTRASOUND INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 REGULATORY TRENDS 
    5.5 REGULATORY ANALYSIS 
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
                                TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.5.1.2 Canada
                                TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.5.2 EUROPE
           5.5.3 ASIA PACIFIC
                    5.5.3.1 Japan
                                TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.5.3.2 China
                                TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.5.3.3 India
    5.6 REIMBURSEMENT SCENARIO 
          TABLE 7 MEDICAL REIMBURSEMENT CPT CODES FOR ULTRASOUND PROCEDURES IN US (AS OF 2021)
    5.7 ECOSYSTEM MAPPING 
    5.8 VALUE CHAIN ANALYSIS 
           5.8.1 RESEARCH & PRODUCT DEVELOPMENT
           5.8.2 RAW MATERIAL AND MANUFACTURING
           5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
                    FIGURE 20 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
    5.9 SUPPLY CHAIN ANALYSIS 
           5.9.1 PROMINENT COMPANIES
           5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.9.3 END USERS
                    TABLE 8 MARKET: SUPPLY CHAIN ECOSYSTEM
                    FIGURE 21 MARKET: SUPPLY CHAIN ANALYSIS
    5.10 PATENT ANALYSIS 
           FIGURE 22 PATENT DETAILS FOR ULTRASOUND (JANUARY 2013–JUNE 2023)
           FIGURE 23 PATENTS FOR DIAGNOSTIC ULTRASOUND SYSTEMS (JANUARY 2013–JUNE 2023)
           FIGURE 24 PATENTS FOR THERAPEUTIC ULTRASOUND SYSTEMS  (JANUARY 2013–JUNE 2023)
    5.11 TRADE ANALYSIS 
           5.11.1 MARKET: TRADE ANALYSIS
                     TABLE 9 IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812),  BY COUNTRY, 2018–2022 (USD)
                     TABLE 10 EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812),  BY COUNTRY, 2018–2022 (USD)
    5.12 KEY CONFERENCES AND EVENTS 
           TABLE 11 MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
    5.13 TECHNOLOGY ANALYSIS 
    5.14 CASE STUDY ANALYSIS 
           TABLE 12 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
           TABLE 13 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING ULTRASOUND TECHNIQUES
    5.15 PRICING ANALYSIS 
           TABLE 14 REGIONAL PRICE RANGE FOR ULTRASOUND SYSTEMS
6 ULTRASOUND MARKET, BY TECHNOLOGY (Page No. - 74)
    6.1 INTRODUCTION 
          TABLE 15 ULTRASOUND INDUSTRY, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    6.2 DIAGNOSTIC ULTRASOUND 
          TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 17 DIAGNOSTIC MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 18 DIAGNOSTIC MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
          TABLE 19 DIAGNOSTIC MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
          TABLE 20 DIAGNOSTIC MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 21 DIAGNOSTIC ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           6.2.1 2D ULTRASOUND
                    6.2.1.1 Strong demand in emerging economies to drive market
                                TABLE 22 2D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.2 3D & 4D ULTRASOUND
                    6.2.2.1 Greater diagnostic accuracy and improved imaging capabilities to boost demand
                                TABLE 23 3D & 4D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.3 DOPPLER ULTRASOUND
                    6.2.3.1 Growing applications in pain management, cardiovascular imaging, and emergency care to drive market
                                TABLE 24 DOPPLER ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.4 CONTRAST-ENHANCED ULTRASOUND
                    6.2.4.1 Availability of technologically advanced instruments to support growth
                                TABLE 25 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.3 THERAPEUTIC ULTRASOUND 
          TABLE 26 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 27 THERAPEUTIC MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 28 THERAPEUTIC MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
          TABLE 29 THERAPEUTIC MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
          TABLE 30 THERAPEUTIC MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 31 THERAPEUTIC ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           6.3.1 HIGH-INTENSITY FOCUSED ULTRASOUND
                    6.3.1.1 Promising results associated with HIFU in cancer treatment to drive market
                                TABLE 32 MARKET, BY REGION,  2021–2028 (USD MILLION)
           6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
                    6.3.2.1 Growing emphasis on minimally invasive treatment of kidney & gallbladder stones to drive demand for ESWL
                                TABLE 33 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY REGION, 2021–2028 (USD MILLION)
7 ULTRASOUND MARKET, BY DISPLAY (Page No. - 87)
    7.1 INTRODUCTION 
          TABLE 34 ULTRASOUND INDUSTRY, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
    7.2 COLOR ULTRASOUND DEVICES 
           7.2.1 RISING AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE MARKET
                    TABLE 35 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 BLACK & WHITE ULTRASOUND DEVICES 
           7.3.1 ASIA PACIFIC REGION TO SHOW SUSTAINED DEMAND
                    TABLE 36 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION,  2021–2028 (USD MILLION)
8 ULTRASOUND MARKET, BY PORTABILITY (Page No. - 91)
    8.1 INTRODUCTION 
          TABLE 37 ULTRASOUND INDUSTRY, BY PORTABILITY, 2021–2028 (USD MILLION)
    8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS 
           8.2.1 RISING USAGE OF TROLLEY-BASED SYSTEMS IN ACUTE & EMERGENCY CARE TO DRIVE MARKET
                    TABLE 38 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION,  2021–2028 (USD MILLION)
    8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS 
           8.3.1 AFFORDABILITY AND PROCEDURAL & TECHNICAL BENEFITS TO DRIVE MARKET
                    TABLE 39 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.4 POC ULTRASOUND SYSTEMS 
           8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
                    TABLE 40 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 ULTRASOUND MARKET, BY APPLICATION (Page No. - 96)
    9.1 INTRODUCTION 
          TABLE 41 ULTRASOUND INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 RADIOLOGICAL/GENERAL IMAGING APPLICATIONS 
           9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES TO DRIVE MARKET
                    TABLE 42 MARKET FOR RADIOLOGICAL/GENERAL IMAGING APPLICATIONS,  BY REGION, 2021–2028 (USD MILLION)
    9.3 CARDIOLOGICAL APPLICATIONS 
           9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE MARKET
                    TABLE 43 MARKET FOR CARDIOLOGICAL APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.4 OBSTETRIC/GYNECOLOGICAL APPLICATIONS 
           9.4.1 WIDE USAGE IN OB/GYN APPLICATIONS TO BOOST GROWTH
                    TABLE 44 MARKET FOR OBSTETRIC/GYNECOLOGICAL APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.5 UROLOGICAL APPLICATIONS 
           9.5.1 GROWING PREVALENCE OF UROLOGICAL DISORDERS TO SUPPORT MARKET
                    TABLE 45 MARKET FOR UROLOGICAL APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.6 VASCULAR APPLICATIONS 
           9.6.1 VASCULAR APPLICATIONS TO WITNESS HIGH GROWTH
                    TABLE 46 MARKET FOR VASCULAR APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.7 ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS 
           9.7.1 RISING PATIENT PREFERENCE FOR EARLY DIAGNOSIS TO DRIVE MARKET
                    TABLE 47 MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
    9.8 PAIN MANAGEMENT APPLICATIONS 
           9.8.1 INCREASING USE IN TRAUMA & EMERGENCY CARE TO SUPPORT MARKET GROWTH
                    TABLE 48 MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.9 OTHER APPLICATIONS 
          TABLE 49 MARKET FOR OTHER APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
10 ULTRASOUND MARKET, BY COMPONENT (Page No. - 105)
     10.1 INTRODUCTION 
             TABLE 50 ULTRASOUND INDUSTRY, BY COMPONENT, 2021–2028 (USD MILLION)
     10.2 TRANSDUCERS/PROBES 
             TABLE 51 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 52 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY REGION,  2021–2028 (USD MILLION)
             10.2.1 CURVILINEAR/CONVEX ARRAYS
                        10.2.1.1 Growing adoption of POC ultrasound to support growth
                                      TABLE 53 CURVILINEAR/CONVEX ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
             10.2.2 LINEAR ARRAYS
                        10.2.2.1 Rising target patient population to drive market
                                      TABLE 54 LINEAR ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
             10.2.3 PHASED ARRAYS
                        10.2.3.1 Technological advancements to drive market
                                      TABLE 55 PHASED ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
             10.2.4 OTHER ARRAY TYPES
                        TABLE 56 OTHER ARRAY TYPES MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.3 WORKSTATIONS 
             10.3.1 GROWING DIAGNOSTIC PROCEDURAL VOLUMES TO FUEL DEMAND FOR WORKSTATIONS
                        TABLE 57 ULTRASOUND WORKSTATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.4 OTHER COMPONENTS 
             TABLE 58 OTHER ULTRASOUND COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
11 ULTRASOUND MARKET, BY END USER (Page No. - 112)
     11.1 INTRODUCTION 
             TABLE 59 ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 
             11.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR ULTRASOUND
                        TABLE 60 MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
     11.3 MATERNITY CENTERS 
             11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND FOR OB/GYN APPLICATIONS TO BOOST GROWTH
                        TABLE 61 MARKET FOR MATERNITY CENTERS, BY REGION,  2021–2028 (USD MILLION)
     11.4 AMBULATORY CARE CENTERS 
             11.4.1 INCREASING EMPHASIS ON AMBULATORY CARE TO SUPPORT MARKET GROWTH
                        TABLE 62 MARKET FOR AMBULATORY CARE CENTERS, BY REGION,  2021–2028 (USD MILLION)
     11.5 RESEARCH & ACADEMIA 
             11.5.1 GROWING AVAILABILITY OF RESEARCH GRANTS & FUNDING TO DRIVE GROWTH
                        TABLE 63 MARKET FOR RESEARCH & ACADEMIA, BY REGION,  2021–2028 (USD MILLION)
     11.6 OTHER END USERS 
             TABLE 64 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
12 ULTRASOUND MARKET, BY REGION (Page No. - 119)
     12.1 INTRODUCTION 
             TABLE 65 ULTRASOUND INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     12.2 NORTH AMERICA 
             FIGURE 25 NORTH AMERICA: ULTRASOUND MARKET SNAPSHOT
             TABLE 66 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 67 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 68 NORTH AMERICA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 69 NORTH AMERICA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 70 NORTH AMERICA: MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
             TABLE 71 NORTH AMERICA: MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
             TABLE 72 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 73 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.1 US
                        12.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market
                                      TABLE 74 POCUS ULTRASOUND CPT CODES (2021)
                                      TABLE 75 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 76 US: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 77 US: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.2.2 CANADA
                        12.2.2.1 Growing awareness about early disease diagnosis to drive market
                                      TABLE 78 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 79 CANADA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 80 CANADA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
     12.3 EUROPE 
             TABLE 81 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 82 EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 83 EUROPE: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 84 EUROPE: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 85 EUROPE: MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
             TABLE 86 EUROPE: MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
             TABLE 87 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 88 EUROPE: ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.3.1 GERMANY
                        12.3.1.1 Increasing healthcare expenditure and government spending to drive market
                                      TABLE 89 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 90 GERMANY: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 91 GERMANY: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.2 FRANCE
                        12.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market
                                      TABLE 92 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 93 FRANCE: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 94 FRANCE: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.3 UK
                        12.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market
                                      TABLE 95 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 96 UK: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 97 UK: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.4 ITALY
                        12.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
                                      TABLE 98 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 99 ITALY: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 100 ITALY: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.5 SPAIN
                        12.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market
                                      TABLE 101 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 102 SPAIN: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 103 SPAIN: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.6 REST OF EUROPE
                        TABLE 104 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 105 REST OF EUROPE: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 106 REST OF EUROPE: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
     12.4 ASIA PACIFIC 
             FIGURE 26 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
             TABLE 107 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 108 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 109 ASIA PACIFIC: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 110 ASIA PACIFIC: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 111 ASIA PACIFIC: MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
             TABLE 112 ASIA PACIFIC: MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
             TABLE 113 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 114 ASIA PACIFIC: ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.4.1 CHINA
                        12.4.1.1 Increasing healthcare reforms and rising government investments to drive market
                                      TABLE 115 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 116 CHINA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 117 CHINA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market
                                      TABLE 118 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 119 JAPAN: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 JAPAN: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.3 INDIA
                        12.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market
                                      TABLE 121 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 122 INDIA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 123 INDIA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.4 AUSTRALIA
                        12.4.4.1 Growing healthcare spending and increasing investments in research to drive market
                                      TABLE 124 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
                                      TABLE 125 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 126 AUSTRALIA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 127 AUSTRALIA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.5 SOUTH KOREA
                        12.4.5.1 Well-developed healthcare system and rising awareness of diseases to drive market
                                      TABLE 128 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 129 SOUTH KOREA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 130 SOUTH KOREA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                        TABLE 131 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 132 REST OF ASIA PACIFIC: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 133 REST OF ASIA PACIFIC: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
     12.5 LATIN AMERICA 
             TABLE 134 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 135 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 136 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 137 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 138 LATIN AMERICA: MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
             TABLE 139 LATIN AMERICA: MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
             TABLE 140 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 141 LATIN AMERICA: ULTRASOUND INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.5.1 BRAZIL
                        12.5.1.1 Greater purchasing power and favorable demographic conditions to drive market
                                      TABLE 142 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 143 BRAZIL: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 144 BRAZIL: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.5.2 MEXICO
                        12.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market
                                      TABLE 145 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 146 MEXICO: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 147 MEXICO: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.5.3 REST OF LATIN AMERICA
                        TABLE 148 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 149 REST OF LATIN AMERICA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 150 REST OF LATIN AMERICA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
     12.6 MIDDLE EAST & AFRICA 
             12.6.1 GROWING MEDICAL TOURISM AND INCREASING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
                        TABLE 151 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 152 MIDDLE EAST & AFRICA: DIAGNOSTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 153 MIDDLE EAST & AFRICA: THERAPEUTIC-ULTRASOUND MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 154 MIDDLE EAST & AFRICA: MARKET, BY DISPLAY TYPE,  2021–2028 (USD MILLION)
                        TABLE 155 MIDDLE EAST & AFRICA: MARKET, BY PORTABILITY,  2021–2028 (USD MILLION)
                        TABLE 156 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 157 MIDDLE EAST & AFRICA: ULTRASOUND INDUSTRY, BY END USER,  2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE (Page No. - 180)
     13.1 OVERVIEW 
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
     13.3 REVENUE SHARE ANALYSIS 
             FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND INDUSTRY, 2022
     13.4 MARKET SHARE ANALYSIS 
             FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN MARKET, 2022
             TABLE 158 MARKET: DEGREE OF COMPETITION
     13.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
                        FIGURE 29 MARKET: COMPANY EVALUATION MATRIX  FOR KEY PLAYERS, 2022
     13.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 STARTING BLOCKS
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 DYNAMIC COMPANIES
                        FIGURE 30 ULTRASOUND INDUSTRY: COMPANY EVALUATION MATRIX  FOR START-UPS/SMES, 2022
     13.7 COMPETITIVE BENCHMARKING 
             TABLE 159 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
             TABLE 160 PRODUCT FOOTPRINT ANALYSIS
             TABLE 161 REGIONAL FOOTPRINT ANALYSIS
     13.8 COMPETITIVE SCENARIO AND TRENDS 
             TABLE 162 PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
             TABLE 163 DEALS, JANUARY 2020–JUNE 2023
             TABLE 164 OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
14 COMPANY PROFILES (Page No. - 193)
     14.1 KEY PLAYERS 
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
             14.1.1 GE HEALTHCARE
                        TABLE 165 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             14.1.2 KONINKLIJKE PHILIPS N.V.
                        TABLE 166 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             14.1.3 CANON MEDICAL SYSTEMS CORPORATION
                        TABLE 167 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
                        FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
             14.1.4 SIEMENS AG
                        TABLE 168 SIEMENS AG: COMPANY OVERVIEW
                        FIGURE 34 SIEMENS AG: COMPANY SNAPSHOT (2022)
             14.1.5 FUJIFILM CORPORATION
                        TABLE 169 FUJIFILM CORPORATION: COMPANY OVERVIEW
                        FIGURE 35 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
             14.1.6 HOLOGIC, INC.
                        TABLE 170 HOLOGIC, INC.: COMPANY OVERVIEW
                        FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
             14.1.7 SAMSUNG ELECTRONICS CO., LTD.
                        TABLE 171 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW
                        FIGURE 37 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
             14.1.8 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
                        TABLE 172 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
                        FIGURE 38 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
             14.1.9 ESAOTE SPA
                        TABLE 173 ESAOTE SPA: COMPANY OVERVIEW
             14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
                        TABLE 174 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
             14.1.11 NEUSOFT CORPORATION
                        TABLE 175 NEUSOFT CORPORATION: COMPANY OVERVIEW
                        FIGURE 39 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2022)
             14.1.12 MOBISANTE, INC.
                        TABLE 176 MOBISANTE, INC.: COMPANY OVERVIEW
             14.1.13 CLARIUS
                        TABLE 177 CLARIUS: COMPANY OVERVIEW
             14.1.14 MEDGYN PRODUCTS, INC.
                        TABLE 178 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW
             14.1.15 PROMED TECHNOLOGY CO., LTD.
                        TABLE 179 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
     14.2 OTHER COMPANIES 
             14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
             14.2.2 TELEMED ULTRASOUND
             14.2.3 SHENZHEN RICSO TECHNOLOGY CO., LTD.
             14.2.4 GUANGDONG YOUKEY MEDICAL CO., LTD.
             14.2.5 ECHONOUS INC.
             14.2.6 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
             14.2.7 SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI)
             14.2.8 BUTTERFLY NETWORK, INC.
             14.2.9 ALPINION MEDICAL SYSTEMS CO., LTD.
             14.2.10 EDAN INSTRUMENTS, INC.
15 APPENDIX (Page No. - 251)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS